The South & Central America percutaneous mechanical circulatory support devices market is expected to reach US$ 122.51 million by 2027 from US$ 50.10 million in 2019; it is estimated to grow at a CAGR of 12.1% from 2020 to 2027.
The rising geriatric population, and increasing prevalence of cardiovascular diseases are the key factors driving the growth of percutaneous mechanical circulatory support devices. However, high costs of these devices and procedures associated with them, and impact of COVID-19 pandemic on medical device industry is the major factor hindering the Percutaneous mechanical circulatory support devices market growth in South & Central America.
Percutaneous mechanical circulatory support devices offer an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.
The developed countries depend on a healthcare model in which healthcare professions treat medical conditions with the help of medications and surgeries. However, in developing countries, more focus is on holistic and conventional treatment methods on a large scale. Major differences between developed and developing countries are resources like money, infrastructure, skilled workforce, education, and products. Healthcare in developing countries is undergoing rapid changes. The healthcare systems in those countries are facing challenges such as the burden of rising and aging populations, and with it, the delivery of adequate healthcare to the masses.
The healthcare infrastructure in large cities of developing countries may have all the necessary amenities, but rural areas may not. Thus, these massive unexplored areas pose as ample revenue generation opportunities for percutaneous mechanical circulatory support devices market, as cardiovascular diseases are among the prominently prevalent health conditions within these economies. Countries like Brazil and Argentina have a large patient population base, and the healthcare expenditure is increasing, thus illustrating immense healthcare market potential. Thus, with the growing healthcare industry and increasing government initiatives, the demand for percutaneous mechanical circulatory support devices is expected to increase in the developing economies.
Covid-19 pandemic is making its way to all South & Central America countries. In Brazil, the number of confirmed cases are 79,400 with 5,500 reported death. With the growing number of surgeries, Brazil government has taken initiative to support healthcare professional. For instance, as per the Health Ministry, Brazil’s government has distributed over 14.2 million surgical masks national wide to prevent the growing number of COVID-19 cases. These regions are facing huge problem, as they are low-cost regions. Additionally, these regions are known for its medical tourism industry, however, due to COVID-19 the Brazil have restricted travelling that has significantly affected the medical tourism industry. Additionally, increasing ill patients in low-cost regions are more prone to death by COVID-19 as healthcare professionals have limited their checking of patients.
Rest of South & Central America Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
SOUTH & CENTRAL AMERICA PERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION
By Product
- Intra-Aortic Balloon Pumps
- VA-Extracorporeal Membrane Oxygenation (ECMO)
- Short-Term Ventricular Assist Devices (VADs)
- Impella
- Tandem Heart
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- Brazil
- Argentina
Company Profiles
- Abbott
- Livanova Plc (Cardiacassist, Inc)
- Eurosets
- Berlin Heart
- Medtronic
South and Central America Percutaneous Mechanical Circulatory Support Devices Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 50.10 Million |
Market Size by 2027 | US$ 122.51 Million |
Global CAGR (2020 - 2027) | 12.1% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















